Related references
Note: Only part of the references are listed.Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays
Xing-Feng Ren et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
A tellurium-based cathepsin B inhibitor: Molecular structure, modelling, molecular docking and biological evaluation
Ignez Caracelli et al.
JOURNAL OF MOLECULAR STRUCTURE (2012)
Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs
Jorge A. R. Salvador et al.
NATURAL PRODUCT REPORTS (2012)
Anticancer effect of A-ring or/and C-ring modified oleanolic acid derivatives on KB, MCF-7 and HeLa cell lines
Barbara Bednarczyk-Cwynar et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions
Leo A. Hardegger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Acridone alkaloids as potent inhibitors of cathepsin V
Richele P. Severino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments
Leo A. Hardegger et al.
CHEMMEDCHEM (2011)
Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product
Nighat Sultana
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2011)
New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
Michael B. Sporn et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion
Bernadette C. Victor et al.
BREAST CANCER RESEARCH (2011)
Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
Koji Tomoo
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
2-Chlorovinyl Tellurium Dihalides, (p-tol)Te[C(H)=C(Cl)Ph]X-2 for X = Cl, Br and I: Variable Coordination Environments, Supramolecular Structures and Docking Studies in Cathepsin B
Ignez Caracelli et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2010)
Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex
Christopher J. Linnevers et al.
PROTEIN SCIENCE (2010)
Antitumoractive Endoperoxides from Triterpenes
Anja Niesen et al.
ARCHIV DER PHARMAZIE (2009)
Impact of Natural Products on Developing New Anti-Cancer Agents
Gordon M. Cragg et al.
CHEMICAL REVIEWS (2009)
Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban
Jacinda T. James et al.
MOLECULES (2009)
Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion
Olga Vasiljeva et al.
BIOCHIMIE (2008)
Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype
Michael C. Myers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on aromatase inhibition
Simone C. B. Gnoatto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
The cathepsin family and their role in colorectal cancer
Doerthe Kuester et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines
Gleice da Graca Rocha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer
Katherine M. Bell-McGuinn et al.
CANCER RESEARCH (2007)
Antibacterial triterpenes from Syzygium guineense (Myrtaceae)
JD Djoukeng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Cysteine proteases as disease markers
I Berdowska
CLINICA CHIMICA ACTA (2004)
Tirucallane-type triterpenes from Juliania adstringens
M Makino et al.
PHYTOCHEMISTRY (2004)
Two novel triterpenes from the leaves of Ficus microcarpa
YH Kuo et al.
HELVETICA CHIMICA ACTA (2004)
Dirhamnosyl flavonoid and other constituents from Brilantaisia palisatii
LF Berrondo et al.
QUIMICA NOVA (2003)
Natural products for cancer prevention: a global perspective
L Reddy et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Design of noncovalent inhibitors of human cathepsin L.: From the 96-residue proregion to optimized tripeptides
SF Chowdhury et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Anti-inflammatory activity of lupeol and lupeol linoleate in rats
T Geetha et al.
JOURNAL OF ETHNOPHARMACOLOGY (2001)
Share Paper
